Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio.
作者信息
Kearney Niamh, McCourt Collette, Hambly Roisin, Hughes Rosalind, O'Kane Donal, Kirby Brian
机构信息
Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.
Department of Dermatology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
出版信息
JAMA Dermatol. 2023 Feb 1;159(2):222-224. doi: 10.1001/jamadermatol.2022.5710.
Abstract
摘要
相似文献
1
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio.
JAMA Dermatol. 2023 Feb 1;159(2):222-224. doi: 10.1001/jamadermatol.2022.5710.
2
Associations between the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio and hidradenitis suppurativa: a systematic review and meta-analysis.
Arch Dermatol Res. 2024 Sep 14;316(9):628. doi: 10.1007/s00403-024-03365-7.
3
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa.
Expert Opin Drug Metab Toxicol. 2020 Nov;16(11):1019-1037. doi: 10.1080/17425255.2020.1810233. Epub 2020 Oct 12.
4
Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study.
J Dermatol. 2022 Dec;49(12):1238-1244. doi: 10.1111/1346-8138.16558. Epub 2022 Aug 24.
5
Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real-life experience and therapeutic response to other biological drugs.
Dermatol Ther. 2022 Dec;35(12):e15866. doi: 10.1111/dth.15866. Epub 2022 Oct 13.
6
Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis.
J Am Acad Dermatol. 2024 Jul;91(1):170-172. doi: 10.1016/j.jaad.2024.03.028. Epub 2024 Mar 28.
7
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.
9
Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
Actas Dermosifiliogr. 2023 Oct;114(9):772-783. doi: 10.1016/j.ad.2023.05.015. Epub 2023 May 19.
10
Biologic Treatment for Hidradenitis Suppurativa.
Am J Clin Dermatol. 2019 Oct;20(5):625-638. doi: 10.1007/s40257-019-00439-5.
引用本文的文献
1
Pathogenic bacteria features of central line-associated bloodstream infections in ICU patients: focus on the early predictive value of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios.
Front Cell Infect Microbiol. 2025 Apr 30;15:1525758. doi: 10.3389/fcimb.2025.1525758. eCollection 2025.
2
Associations between the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio and hidradenitis suppurativa: a systematic review and meta-analysis.
Arch Dermatol Res. 2024 Sep 14;316(9):628. doi: 10.1007/s00403-024-03365-7.
3
Blood-Count-Derived Inflammatory Markers as Predictors of Response to Biologics and Small-Molecule Inhibitors in Psoriasis: A Multicenter Study.
J Clin Med. 2024 Jul 9;13(14):3992. doi: 10.3390/jcm13143992.
4
Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.
Int J Mol Sci. 2023 Apr 9;24(8):6969. doi: 10.3390/ijms24086969.
Zotero 插件